Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Extends Device, Drug Accelerated Access Review Until April 2016

This article was originally published in Clinica

Executive Summary

A UK government project that is exploring how to support the faster development of, and access to, new drugs and medical devices for patients under the National Health Service will now be finalized in April 2016, rather than at the end of this year as was originally intended. An interim report on the accelerated access review (AAR) project, which is looking at new product development pathways among other things, will be published in October as planned.


Related Content

UK Accelerated Access Proposals Due Out Soon





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts